Cargando…
Risk Profiling of Cancer Treatment-Related Cardiovascular Disorders in Breast Cancer Patients Who Received Adjuvant Chemotherapy With Trastuzumab
Background: The prognosis of cancer survivors has dramatically improved, but effective strategies for cancer treatment-related cardiovascular disorders (CTRCD) remain to be elucidated in the emerging field of cardio-oncology. In this study, we investigated risk factors for CTRCD in breast cancer pat...
Autores principales: | Shinano, Hiromi, Miyazaki, Sakiko, Miura, Kayo, Ohtsu, Hiroshi, Yonemoto, Naohiro, Matsuoka, Kiyoshi, Konishi, Hakuou, Daida, Hiroyuki, Saito, Mitsue, Sase, Kazuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921354/ https://www.ncbi.nlm.nih.gov/pubmed/33693235 http://dx.doi.org/10.1253/circrep.CR-19-0119 |
Ejemplares similares
-
Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis
por: Ohtsu, Hiroshi, et al.
Publicado: (2022) -
Endovascular versus open repair in patients with abdominal aortic aneurysm: a claims-based data analysis in Japan
por: Kimura, Yuki, et al.
Publicado: (2022) -
Cardiotoxicity after Additional Administration of Pertuzumab following Long-Term Trastuzumab: Report of 2 Cases
por: Ito, Mayuko, et al.
Publicado: (2021) -
Involvement of kallikrein‐PAR2‐proinflammatory pathway in severe trastuzumab‐induced cardiotoxicity
por: Sasaki, Ritsuko, et al.
Publicado: (2022) -
Real-World Evidence in Cardio-Oncology: What Is It and What Can It Tell Us?
por: Ohtsu, Hiroshi, et al.
Publicado: (2022)